YAY,
Chicken study PR. Asked for and received. Industry spend on it only $1.5 billion so that is partly why there's no great reaction to it. If ZIVO capture 10% of market .... it is still $150 million in potential revenues. Not bad. With partner though that number surely goes down more. But nonetheless ...... the test should be over beginning of December and results by end of year. I assume the test started the week of the 18th but they didn't say specifically in the PR.
Anyway a successful test is a springboard to other things. ZIVO's cash issue can disappear in a flash via big pharma petty cash license/partnership arrangement. Who gonna produce it and all is also a factor.
Gwinner I assume you are talking about a buyout ..... if successful with chickens it is only tip of iceberg. ZIVO valuation would have to include potential verticals ... although not proven ..... would need some consideration.
Anyway, hoping this time they don't F it up for once. If you have to park an MD on the doorstep of the trial venue and watch every damn detail like a hawk ... then do it. There can't be any excuses this time.
Amigo Mike
News 
Market Data 
Discover 
